Toward personalized immunotherapy in sepsis: The PROVIDE randomized clinical trial.
Cell Rep Med
; 3(11): 100817, 2022 11 15.
Article
in En
| MEDLINE
| ID: mdl-36384100
Full text:
1
Database:
MEDLINE
Main subject:
Sepsis
/
Macrophage Activation Syndrome
Type of study:
Clinical_trials
Limits:
Humans
Language:
En
Year:
2022
Type:
Article